Minority groups have been disproportionately affected by the coronavirus. Should they be prioritized when we’re distributing the vaccine?
As Oxford University’s vaccine entered its final trial phase, and experts noted that the vaccine could appear before the end of the year, the chair of the U.K.’s COVID-19 task force, Kate Bingham, appeared on a national morning show last week to announce preliminary recommendations from the country’s Joint Committee on Vaccination and Immunisation. She announced that the independent group had recommended to the government to prioritize four groups for a vaccine: people over 50, people with additional health conditions, front-line workers—and ethnic minorities.
Read the full article here.
This content was originally published by Fast Company. Original publishers retain all rights. It appears here for a limited time before automated archiving. By Fast Company